CLINICAL ROLE -
Barriers Persist To Implement Teplizumab In Clinical Practice
Teplizumab is indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and pediatric patients 8 years of age and older with stage 2 T1D.
Read More
Doxycycline for Post-Exposure Prophylaxis of Sexually Transmitted Infections
In addition to growing rates of STIs, there is concern for antimicrobial resistance to STIs.